Armistice Capital Reduces Stake in Avanos Medical, Inc. to 4.3%

On May 15, 2026, Armistice Capital, LLC and Steven Boyd filed a Schedule 13G/A regarding their holdings in Avanos Medical, Inc. (AVNS). The filing reports that the reporting persons beneficially own 2,000,000 shares of common stock, representing a 4.3% ownership stake in the company. This represents a decrease in ownership compared to prior filings, as the reporting persons now hold less than the 5% threshold typically required for active reporting, leading to the filing of this amendment. Armistice Capital, LLC serves as the investment manager to the Armistice Capital Master Fund Ltd., which is the direct holder of the shares. Steven Boyd, as the managing member of Armistice Capital, LLC, may be deemed to share voting and dispositive power over these securities. The shares were acquired in the ordinary course of business and are not held for the purpose of influencing or changing the control of the issuer. The event triggering this specific filing occurred on March 31, 2026.